Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: one-year results from the SYNTAX trial.
about
Patient-level costs of major cardiovascular conditions: a review of the international literatureCost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspectiveTreatment for stable coronary artery disease: a network meta-analysis of cost-effectiveness studiesA value-based analysis of hemodynamic support strategies for high-risk heart failure patients undergoing a percutaneous coronary intervention.Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents in patients with multivessel coronary artery disease compared to coronary artery bypass surgery five-years after intervention.Carotid artery stenosis: cost-effectiveness of assessment of cerebrovascular reserve to guide treatment of asymptomatic patients.Stratification of coronary artery disease patients for revascularization procedure based on estimating adverse effects.Strategies for Primary Prevention of Coronary Heart Disease Based on Risk Stratification by the ACC/AHA Lipid Guidelines, ATP III Guidelines, Coronary Calcium Scoring, and C-Reactive Protein, and a Global Treat-All Strategy: A Comparative--EffectiveCost-Effectiveness of Carotid Plaque MR Imaging as a Stroke Risk Stratification Tool in Asymptomatic Carotid Artery Stenosis.Focused Cardiac Ultrasound in Place of Repeat Echocardiography: Reliability and Cost Implications.Cost-effectiveness of percutaneous coronary intervention with drug eluting stents versus bypass surgery for patients with diabetes mellitus and multivessel coronary artery disease: results from the FREEDOM trial.Weighting composite endpoints in clinical trials: essential evidence for the heart team.Multivessel coronary artery disease: quantifying how recent trials should influence clinical practice.Comparative effectiveness of revascularization strategies in stable ischemic heart disease: current perspective and literature review.The cost-effectiveness of strategies in coronary artery disease.Comparison of coronary artery bypass graft surgery and percutaneous coronary intervention in patients with diabetes.Guidelines versus reality: is coronary stent application in three-vessel disease standard or the exception?Clinical Trials Versus Clinical Practice: When Evidence and Practice Diverge--Should Nondiabetic Patients With 3-Vessel Disease and Stable Ischemic Heart Disease Be Preferentially Treated With CABG?Estimates of absolute treatment benefit for individual patients required careful modeling of statistical interactions.Drug-eluting stents in multivessel coronary artery disease: cost effectiveness and clinical outcomes.Long-term clinical outcomes, health-related quality of life, and costs in different treatment modalities of stable coronary artery disease.Cost-effectiveness of magnetic resonance carotid plaque imaging for primary stroke prevention in Canada.Coronary bypass surgery versus percutaneous coronary intervention: cost-effectiveness in Iran: a study in patients with multivessel coronary artery disease.A systematic review of cost-effectiveness of percutaneous coronary intervention vs. surgery for the treatment of multivessel coronary artery disease in the drug-eluting stent era.
P2860
Q28076912-866654AD-341E-42BE-973C-5103F8068C94Q28269638-A0EF6424-77E1-4851-96C8-0E89B2B64866Q28539350-4A1D7D33-975E-444E-9CCF-A9EFFC0D5C80Q33652803-FD35B490-5AA8-4BB6-8F68-408355560E40Q34669846-9A1FAEAE-094A-4100-A751-98D71AF7349FQ35100438-C323143F-92F6-45A2-8149-0813E691C12BQ35108606-CBE3D0D7-BA46-446E-A628-9A5877818FBCQ35793619-F069CB6F-881E-4F77-9A36-0ABED6D7F73EQ36354380-B55F5CD7-C2C9-4128-9C76-C30D010878A8Q36649098-E86DE026-1CF3-4934-9C57-200DB6D06EF0Q36703074-4016EB69-2CF4-479D-8459-7C2B67B1AC9DQ37115639-DE2ECA11-68B1-4BE8-8039-B4BF5424CB36Q38124877-4FD7B74F-BCBA-4B54-9C93-A9B346B71DF2Q38153783-960250DA-834C-45BF-8A15-28EB1FA03B9DQ38255595-43B0E405-6945-42F1-AFD6-71D88124D625Q38387683-49BCE1F5-BD20-4E9E-B417-7FD0118CC04EQ38617401-F5DF440F-17BA-4DE0-8104-40865DF7F558Q41112088-F2EA3C28-D1E6-4724-BA24-9D2008B3775FQ41151931-D68E0AFB-0AF4-4193-B582-C56F1B6CBC34Q41889254-AD494F25-9093-49FE-991E-9753B1C95C2FQ47687627-FAEB01DE-682B-471D-8EA1-65AECDFF8648Q48115342-35AF640B-73D0-4B6B-8CE3-EF411CBF772CQ51034959-869D11DB-F89A-49CA-9BF7-10EA9E55C5DAQ52900784-98D7FCA5-17AF-4302-B4DE-5821DFDDBD88
P2860
Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: one-year results from the SYNTAX trial.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Economic outcomes of percutane ...... results from the SYNTAX trial.
@en
Economic outcomes of percutane ...... results from the SYNTAX trial.
@nl
type
label
Economic outcomes of percutane ...... results from the SYNTAX trial.
@en
Economic outcomes of percutane ...... results from the SYNTAX trial.
@nl
prefLabel
Economic outcomes of percutane ...... results from the SYNTAX trial.
@en
Economic outcomes of percutane ...... results from the SYNTAX trial.
@nl
P2093
P2860
P356
P1476
Economic outcomes of percutane ...... results from the SYNTAX trial.
@en
P2093
A Pieter Kappetein
Ben Van Hout
Carl A Henry
David J Cohen
Duane Pinto
Elizabeth A Magnuson
Friedrich W Mohr
Katherine Robertus
Phillip A Horwitz
P2860
P304
P356
10.1002/CCD.23147
P577
2011-09-26T00:00:00Z